ArticleFrontiers in neurology2025
Clinical efficacy of ultra-laser irradiation combined with gabapentin on elderly patients with cervical spondylotic radiculopathy.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasound-guided brachial plexus hydrodissection combined with acupotomy release for the treatment of cervical spondylotic radiculopathy: a multicenter retrospective study.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Cervical spondylotic radiculopathy is the most prevalent form of cervical spondylosis. This study aimed to investigate the clinical efficacy of ultra-laser irradiation combined with gabapentin for treating elderly patients with cervical spondylotic radiculopathy, providing a basis for optimizing treatment strategies. Methods: In this single-blind randomized controlled trial, 160 elderly patients diagnosed at our hospital from March to June 2025 were assigned (1:1) to ultra-laser irradiation plus gabapentin or gabapentin alone (80 per group). Pain was assessed with the Numerical Rating Scale (NRS) and health status with the EQ-5D at baseline and after three courses of treatment (30 sessions in total). Adverse events were recorded. Results: Baseline NRS scores were similar between groups. After treatment, the between-group difference in NRS improvement was 1.90 points (95% CI 1.64-2.16; Conclusion: Ultra-laser irradiation combined with gabapentin reduced pain, improved health-related quality of life, and was associated with fewer short-term adverse events compared with gabapentin alone. Confirmation with longer follow-up, sham-controlled designs, and cost-effectiveness evaluation is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.